VEGFA and breast carcinoma: Breast cancer progression, particularly the hormone resistant types represented by MDA-MB-231 cells, might be linked with diabetes mellitus complications (hyper/hypoglycemia) through the VEGF pathway since under extreme hypoglycemic conditions VEGFR2 persisted in the cells, did not degrade and was rapidly switched to its mature functional form upon availability of glucose.